Alphapharm To Market “Authorized” Generic Of Forest’s Lexapro
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal allows Alphapharm to launch two weeks before the escitalopram patent expires in December 2009.
You may also be interested in...
Teva’s Lexapro ANDA Receives FDA Approval
Launch awaits outcome of patent litigation with Forest.
Teva’s Lexapro ANDA Receives FDA Approval
Launch awaits outcome of patent litigation with Forest.
Forest Seeks Injunction Against Lexapro Generics
Forest filed a motion for preliminary injunction to prevent Cipla and Ivax from marketing generic versions of Lexapro (escitalopram) in Delaware federal court on Jan. 13